IN THIS INDUSTRY
Geneva and Novartis
Patent Litigation
Schiff Hardin represented Geneva and Novartis in this case with respect to a generic version of the Claritin® brand before both the district and appellate courts.
Lek Pharmaceuticals
Patent Litigation
In the Omeprazole patent litigation Schiff Hardin represented Lek Pharmaceuticals, a subsidiary of Sandoz and Novartis, in its successful defense of AstraZeneca's patent infringement action regarding the plaintiff's Prilosec® product.